Insights Into Myelofibrosis (MF) 2025

Perspectives on drivers in treatment decisions in the management of MF

Southeast – March 21, 2025
Purchase Report

Faculty Chair

Prithviraj Bose, MD

MD Anderson Cancer Center, Houston, TX, USA

Southwest – May 3, 2025
Purchase Report

Faculty Chair

Aaron Gerds, MD

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA

More Information

  • Atlanta, GA
  • Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia

More Information

  • Phoenix, AZ
  • Arizona, Colorado, Nevada, New Mexico, Southern California, Utah

Example Agenda

Download the meeting agenda

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of MF
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies will be obtained
    • Current management and emerging challenges in MF
    • Current therapy paradigms for MF
    • Unmet needs and emerging paradigms

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.